SEC Form 4 · Updated Daily
TBIO
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Sanofi | 10%+ Owner | 75,668,031 | 2021-09-14 | P |
| GLAXOSMITHKLINE PLC | 10%+ Owner | 3,697,912 | 2018-07-02 | P |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2021-09-14 | Sanofi | Open-market buy | 20,515,985 | $38.00 | 75,668,031 |
| 2021-09-14 | Sanofi | Open-market buy | 51,467,612 | $38.00 | 55,152,046 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion (derivative) | 2,525,253 | $0.00 | 0 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion (derivative) | 7,222,797 | $0.00 | 0 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion (derivative) | 9,300,000 | $0.00 | 0 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Open-market buy | 269,230 | $13.00 | 3,697,912 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion | 454,550 | — | 3,428,682 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion | 1,300,116 | — | 2,974,132 |
| 2018-07-02 | GLAXOSMITHKLINE PLC | Conversion | 1,674,016 | — | 1,674,016 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.